Polymorphisms in the TNF-α and IL-10 gene promoters and risk of psoriasis and correlation with disease severity

Cytokine

Volumn 66, Issue 2, 2014, Pages 101-105

  Karam, Rehab A ^a   Zidan, Haidy E ^a   Khater, Mohamed Hamed ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

IL 10; Polymorphisms; Psoriasis; TNF

Indexed keywords

IL-10; POLYMORPHISMS; PSORIASIS; TNF-Α;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84893704824     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.01.008     Document Type: Article

References (43)

1. Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
2. Kimball A.B., Kawamura T., Tejura K., Boss C., Hancox A.R., Vogel J.C., et al. Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo controlled trial using recombinant human interleukin 10. Arch Dermatol 2002, 138(10):1341-1346.
3. Eskdale J., Kube D., Tesch H., Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997, 46(2):120-128.
4. Hirankarn N., Wongpiyabovorn J., Hanvivatvong O., Netsawang J., Akkasilpa S., Wongchinsri J., et al. The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 2006, 68:399-406.
5. Craven N., Jackson C., Kirby B. Cytokine gene polymorphis in psoriasis. Br J Dermatol 2001, 144(4):849-902.
6. Wongpiyabovorn J., Hirankarn N., Ruchusatsawat K., Yooyongsatit S., Asawanonda P., Poovorawan Y. Association of the interleukin-10 distal promoter (-2763A/C) polymorphism with late-onset psoriasis. Clin Exp Dermatol 2008, 33(2):186-189.
7. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4:e1000041.
8. Hohler T., Grossmann S., Stradmann-Bellinghausen B., Kaluza W., Reuss E., de Vlam K., et al. Differential association of polymorphisms in the TNF-alpha region with psoriatic arthritis but not psoriasis. Ann Rheum Dis 2002, 61:213-218.
9. Rahman P., Siannis F., Butt C., Farewell V., Peddle L., Pellett F., et al. TNF alpha polymorphisms and risk of psoriatic arthritis. Ann Rheum Dis 2006, 65:919-923.
10. Gonzalez S., Martinez-Borra J., Lopez-Vazquez A., Garcia-Fernandez S., Torre-Alonso J.C., Lopez-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 2002, 29:973-978.
11. Nishibu A., Oyama N., Nakamura K., Kaneko F. Lack of association of TNF-238A and -308A in Japanese patients with psoriasis vulgaris, psoriatic arthritis and generalized pustular psoriasis. J Dermatol Sci 2002, 29:181-184.
12. Langley R.G., Ellis CN Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician's global assessment. J Am Acad Dermatol 2004, 51:563.
13. K-Kingo S.Koks., Slim H., Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003, 4:455-457.
14. Persico M., Capasso M., Persico E., Masarone M., Renzo A., Spano D., et al. Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 2006, 45(6):779-785.
15. Sargen K., Demaine A.G., Kingsnorth A.N. Cytokine gene polymorphisms in acute pancreatitis. JOP 2000, 1(2):24-35.
16. Burden A.D., Javed S., Bailey M. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 1998, 110(6):958-960.
17. Settin A., Hassan H., El-Baz R., Hassan T. Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt. Indian J Dermatol 2011, 56(3):272-277.
18. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm Res 2012, 61(7):657-663.
19. Reich K., Westphal G., Schulz T. Combined analysis of polymorphisms of the tumor necrosis factor-a and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 1999, 113:214-234.
20. Baran W., Szepietowski J.C., Mazur G., Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol 2008, 88(2):113-116.
21. *0602 allele in psoriatic arthritis. Rheumatology (Oxford) 2002, 41(5):525-530.
22. Gallo E., Cabaleiro T., Román M., Abad-Santos F., Daudén E. Study of genetic polymorphisms in the tumor necrosis factor α promoter region in spanish patients with psoriasis. Actas Dermosifiliogr 2012, 103(4):301-307.
23. Tsunemi Y., Nishibu A., Saeki H., Oyama N., Nakamura K., Kishimoto M., et al. Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 2003, 207:371-374.
24. Li C., Wang G., Gao Y., Liu L., Gao T. TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. J Invest Dermatol 2007, 127:1886-1892.
25. Jia Y., Qin H.J., Zhang J.X., Liu X.L., Li L.J. Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: a meta-analysis. Clin Exp Dermatol 2013, 38(8):836-844.
26. Oestreicher J.L., Walters I.B., Kikuchi T., Gilleaudeau P., Surette J., Schwertschlag U., et al. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001, 1:272-287.
27. Jacob S.E., Nassiri M., Kerdel F.A., Vince V. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediator Inflammat 2003, 12(5):309-313.
28. McInnes I.B., Illei G.G., Dannin C.L., Yarboro C.H., Crane M., Kuroiwa T., et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 2001, 167:4075-4082.
29. Turner D.M., Williams D.M., Sankaran D. An investigation of polymorphism in the interleukin-10 gene. Eur J Immunogenet 1997, 24(1):1-8.
30. Elkayam O., Yaron I., Shirazi I. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 2000, 19(3):101-106.
31. Borska L., Andrys C., Krejsek J., Hamakova K., Kremlacek J., Ettler K., et al. Serum levels of the proinflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen. Int J Dermatol 2008, 47(8):800-805.
32. Alobaidi A.H., Mothana Z., Najem W.S., Alsamarai A.M. Adiponectin IL-10, IL-23 and trace elements serum levels in patients with psoriasis. Am J Derm Venereol 2012, 1(2):6-23.
33. Abanmi A., Al Harthi F., Al Agla R., Khan H.A., Mohamed T. Serum levels of pro-inflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol 2005, 44(1):82-83.
34. Arican O., Aral M., Sasmaz S., Ciragil P. Serum levels of TNF-a, IFN-c, IL-6, IL-8, IL-12, IL-17 & IL-18 in patients with active psoriasis & correlation with disease severity. Mediat Inflammat 2005, 5:273-279.
35. Verghese B., Bhatnagar S., Tanwar R., Bhattacharjee J. Serum cytokine profile in psoriasis. A case-control study in a Tertiary Care Hospital from Northern India. Ind J Clin Biochem 2011, 26(4):373-377.
36. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
37. Miura Y., Thoburn C.J., Bright E.C., Chen W., Nakao S., Hess A.D. Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood 2002, 100:2650-2658.
38. Kube D., Platzer C., von Knethen A., Straub H., Bohlen Hafner M., Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1996, 7:1-7.
39. Laddha N.C., Dwivedi M., Begum R. Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One 2012, 7(12):e52298. 20.
40. Kroeger K.M., Carville K.S., Abraham L.J. The 2308 tumor necrosis factoralpha promoter polymorphism effects transcription. Mol Immunol 1997, 34:391-399.
41. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195-3199.
42. Sariban E, Imamura K, Luebbers R, Kufe D Transcriptional and post-transcriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988, 81(1506):1510.
43. Takahashi H., Tsuji H., Hashimoto Y., Ishida-Yamamoto A., Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010, 35(6):645-649.